Early detection of anti-drug antibodies during initiation of anti-tumour necrosis factor therapy predicts treatment discontinuation in inflammatory bowel disease.

导出原文传递

翻译打印收藏纠错

作者： Quentin,Tournier ^[1] ; Stephane,Paul ^[2] ; Nicolas,Williet ^[1] ; Anne-Emmanuelle,Berger ^[2] ; Pauline,Veyrard ^[1] ; Gilles,Boschetti ^[3] ; Bertrand,Le Roy ^[4] ; Martin,Killian ^[5] ; Jean Marc,Phelip ^[1] ; Bernard,Flourie ^[3] ; Stephane,Nancey ^[3] ; Xavier,Roblin ^[1]

作者单位： Department of Gastroenterology, University Hospital of Saint-Etienne, Saint-Etienne, France. ^[1] Department of Immunology, CIC1408, GIMAP CIRI INSERM U1111, University Hospital of Saint-Etienne, Saint-Etienne, France. ^[2] Department of Gastroenterology, Lyon Sud Hospital, Hospices Civils de Lyon, University Claude Bernard Lyon 1 and INSERM U1111, Lyon, France. ^[3] Department of Surgery, University Hospital of Saint-Etienne, Saint-Etienne, France. ^[4] Department of Internal Medicine, CIC1408, GIMAP CIRI INSERM U1111, University Hospital of Saint-Etienne, Saint-Etienne, France. ^[5]

主题词人类(Humans);炎性肠疾病(Inflammatory Bowel Diseases);前瞻性研究(Prospective Studies);回顾性研究(Retrospective Studies);治疗结果(Treatment Outcome);肿瘤坏死因子α(Tumor Necrosis Factor-alpha)

DOI 10.1111/apt.16333

PMID 33872404

发布时间 2021-08-06

翻译满意度评价：

准确一般字义偏差语意偏离译文作用小提交